Xponance Inc. grew its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 0.9% in the second quarter, HoldingsChannel reports. The fund owned 192,119 shares of the company’s stock after buying an additional 1,795 shares during the period. Xponance Inc.’s holdings in Colgate-Palmolive were worth $18,643,000 as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. Mitchell Sinkler & Starr PA boosted its position in shares of Colgate-Palmolive by 92.6% in the fourth quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock valued at $3,659,000 after acquiring an additional 22,073 shares during the period. Stonehage Fleming Financial Services Holdings Ltd lifted its position in Colgate-Palmolive by 57.1% during the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock worth $30,594,000 after purchasing an additional 139,429 shares during the period. D L Carlson Investment Group Inc. bought a new stake in Colgate-Palmolive during the fourth quarter worth about $3,269,000. Diversify Advisory Services LLC bought a new stake in Colgate-Palmolive during the first quarter worth about $911,000. Finally, TD Asset Management Inc lifted its position in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after purchasing an additional 26,987 shares during the period. Institutional investors own 80.41% of the company’s stock.
Insider Buying and Selling
In related news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last ninety days. Corporate insiders own 0.34% of the company’s stock.
Analysts Set New Price Targets
Read Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
NYSE:CL opened at $103.06 on Monday. The company has a market capitalization of $84.55 billion, a PE ratio of 32.61, a P/E/G ratio of 3.72 and a beta of 0.40. The company has a 50 day simple moving average of $102.71 and a two-hundred day simple moving average of $95.89. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The company had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the firm posted $0.77 EPS. The company’s quarterly revenue was up 4.9% on a year-over-year basis. Research analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- The Risks of Owning Bonds
- Shoe Carnival Stock: One Size Fits All Investors
- Why Invest in High-Yield Dividend Stocks?
- See Why Oracle’s Cloud Infrastructure Growth Demands Attention
- How to Start Investing in Real Estate
- Darden Restaurants Is on the Verge of a Significant Breakout
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.